Dalton to manufacture new med; DKSH takes Tiger Balm to Myanmar;

> The investment arm of Swedish CMDO Recipharm will hold a 25% stake in Pharmanest, a pain drug developer, after making a 8 million Swedish krona investment in it. Release

> Dalton Pharma Services today announced the signing of a drug development and manufacturing contract with Ramsey Lake Pharmaceutical Corp. Release

And Finally... Market expansion specialist DKSH has been hired by Haw Par Healthcare to handle sales of its Tiger Balm pain reliever in Myanmar. Release